Tenaya Therapeutics, Inc.

US$0.36As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TNYAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (50.91%)
Div yield —
ROE (148.16%)
Biotechnology
Beta (5Y) 2.86
PE TTM —
TSR TTM (74.99%)
Mkt cap US$80.77M
ROIC (66.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.396
10.01%
(13.60%)
Hold 12|11|8|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
8.46%
2.06%
4.81%
9.68%
Revenue$M
6.539
6.767
6.984
7.331
3.62%
3.06%
4.11%
11.97%
Peers (US$80.77M)
Cap (US$)
PE
78.36M
—
81.72M
—
Capital
TTM
5Y
10Y
Leveragex
0.111
0.276
0.282
EBIT/Intx
0.857
0.256
0.241
Own earn%
(56.58)
22.82
(6.32)
Sh yield%
20.10
16.92
18.05
Owners
Insiders/Inst%
9.02
86.87
Short interest%
0.85
SBC / revenue%
4.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
32–41
$1 testx
—
Incr. ROIC%
4